AUM$960.7M
Expense Ratio0.40%
NAV$29.14
Holdings66
InceptionNov 1, 2006
Price Chart
Key Statistics
Previous Close
N/ADay Range
N/A52-Week Range
N/AAvg Volume
N/ADividend Yield
N/AExpense Ratio
0.40%AUM
$960.7MShares Outstanding
N/ASector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 99.98% |
| Cash & Others | 0.02% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 95.50% |
| Ireland | 2.95% |
| Other | 1.55% |
Fund Information
- Issuer
- Invesco
- Category
- Healthcare
- Subcategory
- S&P 500
- Inception Date
- Nov 1, 2006
- Description
- The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of all of the components of the S&P 500® Health Care Index, an index that contains the common stocks of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard (GICS).
Similar ETFs
The Invesco S&P 500 Equal Weight Health Care ETF (RYH) is an exchange-traded fund issued by Invesco that launched on Nov 1, 2006. It currently manages $960.7M in assets under management. The fund charges an expense ratio of 0.40%. The fund holds 66 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 21.3% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | MRNA | Moderna Inc | 3.19% | 423,914 | $23.3M |
| 2 | DVA | DaVita Inc | 2.15% | 103,653 | $15.7M |
| 3 | GILD | Gilead Sciences Inc | 2.06% | 101,426 | $15.1M |
| 4 | VTRS | Viatris Inc | 2.05% | 1,061,136 | $14.9M |
| 5 | MRK | Merck & Co Inc | 2.02% | 126,088 | $14.8M |
| 6 | AMGN | Amgen Inc | 2.01% | 39,019 | $14.6M |
| 7 | JNJ | Johnson & Johnson | 1.99% | 59,580 | $14.5M |
| 8 | BMY | Bristol-Myers Squibb Co | 1.98% | 240,363 | $14.5M |
| 9 | HCA | HCA Healthcare Inc | 1.93% | 26,249 | $14.1M |
| 10 | MCK | McKesson Corp | 1.93% | 15,143 | $14.1M |
| 11 | VRTX | Vertex Pharmaceuticals Inc | 1.89% | 27,680 | $13.8M |
| 12 | DGX | Quest Diagnostics Inc | 1.89% | 68,531 | $13.8M |
| 13 | CAH | Cardinal Health Inc | 1.85% | 62,087 | $13.5M |
| 14 | REGN | Regeneron Pharmaceuticals Inc | 1.79% | 16,946 | $13.1M |
| 15 | BIIB | Biogen Inc | 1.79% | 69,325 | $13.1M |
Page 1 of 2
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | N/A | — | ||
| 1W | N/A | — | ||
| 1M | N/A | — | ||
| 3M | N/A | — | ||
| 6M | N/A | — | ||
| YTD | N/A | — | ||
| 1Y | N/A | — | ||
| 3Y | +2.71% | — | ||
| 5Y | +8.13% | — |
Moving Averages
20-Day MA
N/A
50-Day MA
N/A
200-Day MA
N/A
Price with Moving Averages
Support & Resistance
52-Week High
N/A
Current Price
N/A
52-Week Low
N/A
Current Yield
N/A
Annual Dividend
N/A
Frequency
N/A
Last Ex-Date
N/A
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | RYH | Healthcare(223 ETFs) | S&P 500(415 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.40% | 0.60% | 0.74% |
| AUM | $960.7M | $1.25B | $9.52B |
| Dividend Yield | — | 2.75% | 3.76% |
| Avg Volume | N/A | 769.9K | 1.3M |
| Holdings | 66 | 182 | 90 |
| Performance | |||
| 1-Month Return | — | -3.02% | -1.49% |
| 6-Month Return | — | +5.85% | +2.47% |
| YTD Return | — | +0.17% | +0.16% |
| 1-Year Return | — | +16.65% | +12.68% |
Compare with Another ETF
Search for an ETF to compare with RYH: